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TABLE 1. Risk of postoperative adverse events in patients who received clopidogrel versus control subjects before coronary artery bypass grafting
Outcome end points No. of studies Subjects Statistical method Effect estimate 95% CI
Immediate postoperative mortality 13 12,129 Risk ratio (M-H, random, 95% CI) 1.28 0.99–1.66
Reoperation for bleeding 14 10,944 Risk ratio (M-H, random, 95% CI) 1.78 1.28–2.48
Stroke 7 4422 Risk ratio (M-H, random, 95% CI) 1.28 0.61–2.70
Myocardial infarction 11 4084 Risk ratio (M-H, random, 95% CI) 0.64 0.49–0.83
Postoperative blood loss 10 3186 Mean difference (IV, random, 95% CI) 157.77 61.91–253.63
Red blood cell transfusion 9 10,026 Risk ratio (M-H, random, 95% CI) 1.23 1.10–1.37
Transfused red blood cells (units) 7 2369 Mean difference (IV, random, 95% CI) 0.77 0.05 to 1.59
Transfused fresh-frozen plasma (units) 7 2369 Mean difference (IV, random, 95% CI) 0.31 0.12–0.50
Transfused platelets (units) 6 741 Mean difference (IV, random, 95% CI) 2.41 0.03 to 4.86
CI, Confidence interval; M-H, Mantel-Henzel method; IV, inverse variance method.
Letters to the Editormany patients with recent acute coro-
nary syndrome and those in whom per-
cutaneous coronary interventions were
likely performed, we believe that pa-
tients for whom it was possible to dis-
continue clopidogrel 5 to 7 days before
surgery were those who were in stable
condition permitting delay of surgery
and therefore not requiring urgent or
emergency surgery. Their inclusion
would have been a potential source
of bias.
Here we take also the opportunity
to comment briefly on the differences
and similarities of these 2 meta-
analyses to get more conclusive
results on this controversial issue. In
addition to excluding studies in which
control subjects were exposed to clo-
pidogrel, we excluded from our analy-
sis those studies in which aprotinin
was used in most or all patients, be-
cause its use could have had a major
effect in reducing the risk of major
postoperative bleeding. Importantly,
we excluded studies that included pa-
tients who underwent valve surgery,
which may have significantly affected
the results of meta-analysis. The study
by Nijjer and colleagues1 did not share
these important exclusion criteria. De-
spite these methodologic differences,
our studies reached similar conclu-
sions. In fact, it seems rather clear
that recent exposure to clopidogrel be-
fore coronary surgery is associated
with increased risk of excessive bleed-
ing and need for reexploration. Fur-
thermore, in both meta-analyses we
observed a trend toward increased
mortality with recent exposure toThe Journalclopidogrel, which is consistent in
most of the included studies.
Because excessive bleeding is ama-
jor determinant of postoperative out-
come,3 we conclude that continuing
clopidogrel until the time of coronary
artery bypass grafting may expose pa-
tients to an increased risk of excessive
bleeding and its related complica-
tions. These results must be viewed,
however, in the light of suboptimal de-
sign and analysis of the included
studies.
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To the Editor:
We greatly appreciated reading the
simple but clear case report by Noda
and colleagues1 of awake thoracoscopic
surgery for intractable pneumothorax.
Noda and colleagues1 demonstrated
the benefits of local and epidural anes-
thesia in treating a particular patient
who had right pneumothorax after left
pneumonectomy for cancer. The proce-
dure was both well tolerated and suc-
cessful in completely controlling the
air leakage.
We agreewith Noda and colleagues1
that lesions situated next to the hilum
may present some difficulties in ap-
proach when operating on a breathing
lung. Nevertheless, we would first con-
tend that pulmonary tears causing air
leakage are more frequently situated
in the peripheral surface of the lung
and are therefore verywell suited to ap-
proaches performed with epidural an-
esthesia. Second, we advocate that
even hilar lesions can be reached and
treated in an awake modality after ade-
quate training.
Noda and colleagues1 also stated that
total lung collapse cannot be obtained
in patients who have limited contralat-
eral pulmonary function. In our own
awake series,2 however, lung collapse
was most of the time equivalent to
that achieved with single-lung ventila-
tion. In addition, we found that awake
video-assisted thoracoscopic manage-
ment of pneumothorax is particularly
feasible for and well tolerated by el-
derly patients and those with poorry c Volume 143, Number 1 249
TABLE 1. Ten years of awake thoracic surgery with local or epidural anesthesia
Indications Year N Morbidity (no.)
Mean hospital
stay (d)
Mean global operating
room time (min)
Shift to general
anesthesia (no.)
Pulmonary nodules (median and IQR) 2004 30 1 (3.3%) 2.0 (2–3) 65 (56–72) 2 (6.6%)
Bilateral sympathectomy (mean  SD) 2005 15 — 1.0 86.5  5.7 —
Nonresectional lung volume reduction
(mean  SD)
2006 12 3 (25%) 7.8  5 88  12 1 (8.3%)
Pneumothorax (mean  SD) 2007 21 3 (14.2%) 2.0  1.0 78  20 —
Lung metastases (median and IQR) 2007 14 1 (7.1%) 2.5 (2–3) 62.5 (55–70) —
Decortication (median and IQR) 2010 19 6 (31.6%) 6 (5–7) 50 (40–70)* 4 (21%)
IQR, Interquartile range. *Intraoperative time.
Letters to the Editorgeneral conditions.2 In response to the
surgeon’s suggestions, the patient can
spontaneously regulate the breath,
ventilating more slowly in case of the
onset of hypercapnia or more deeply
when the re-expansion of the lung
is required. Although these actions
may lengthen the operative time, they
favor lungmanipulation and ultimately
avoid endotracheal intubation.
Since 2001, we have successfully
established a structured program of
awake thoracic surgery conducted
with local or epidural anesthesia.3
Apart from pneumothorax, we have
obtained excellent results for such
other conditions as pleural decortica-
tion in empyema thoracis4 and nonre-
sectional surgery for advanced
emphysema5 (Table 1). We have thus
become familiar with procedures per-
formed in hypoxic patients, who repre-
sent the optimal candidates for awake
surgery as well as the most tolerant
of intraoperative hypercapnia.
It is our understanding that operating
with a breathing lung can represent
a conceptual obstacle formany thoracic
surgeons. However, they should con-
sider more often the possibility of
working with a lung in movement and
gain practice with this new situation.
We have found that the learning curve
for surgeons well trained in video-
assisted thoracoscopic surgery is not
longer than that required for any other
new endoscopic procedure. Similarly,
with the increases in the surgical profi-
ciency, we found increasingly higher
postoperative satisfaction levels of
both patients and their referring
physicians.250 The Journal of Thoracic and CIn addition, the avoidance of gen-
eral anesthesia may have significant
positive implications for immune re-
sponse after surgery. We have hypoth-
esized that the lower incidence of
postsurgical infections and the atten-
dant lesser rate of morbidity, faster re-
covery, and shorter hospital stay may
be attributable to this condition.6 In-
deed, a more competent postoperative
immunologic response might be con-
sidered a useful effect even in surgical
oncology, as it would possibly reduce
the probability of future relapses. The
awake surgical resection of the tho-
racic neoplasm represents a new and
challenging frontier that we have re-
cently undertaken to explore.
To date, we think that surgery per-
formed in awake, spontaneously
breathing patients with local and epi-
dural or solely epidural anesthesia
may meet all the requirements for
a safe and effective use in many proce-
dures of thoracic surgery. We are con-
fident that in the near future it can
become part of the routine practice of
the thoracic surgeons.
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We read with interest the letter of
Mineo and Ambrogi concerning our
novel technique for the surgical man-
agement with local and epidural anes-
thesia of intractable pneumothorax
after pneumonectomy. We appreciate
all the useful comments that we have
received in response to the submission
of our article.1
We initially believed that it might be
difficult to approach lesions located
near the hilum; however, we are now
encouraged by the comments ofMineo
and Ambrogi stating that hilar lesions
can be approached and treated in awake
patients after adequate surgical train-
ing. In addition, we have highlighted
the importance of identifying any
potential air leakage sites before per-
forming thoracic surgery on awake
patients. In our own recent study,
preoperative thoracography with iopa-
midol (Iopamiron 300; Schering
AG, Berlin, Germany) was therefore
performed through a double-lumen
chest tube. The appropriate treatment
